Cannabidiol (CBD), a compound derived from the cannabis plant that does not produce a “high” and has been an increasing focus of medical research, was shown in a new large-scale, randomized, controlled trial to significantly reduce the number of dangerous seizures in patients with a severe form of epilepsy called Lennox–Gastaut syndrome. In the new study comparing 2 doses of CBD to a placebo, the researchers reported a 41.9 percent reduction in “drop seizures”—a type of seizure that results in severe loss of muscle control and balance—in patients taking a 20 mg/kg/d CBD regimen, a 37.2 percent reduction in those on a 10 mg/kg/d CBD regimen, and a 17.2 percent reduction in a group given a placebo.
While a Food and Drug Administration advisory panel recently recommended pharmaceutical-grade cannabidiol (CBD) as a treatment for two rare forms of epilepsy, CBD medication is not the same thing as medical marijuana, which is more available than ever before and promoted for wide variety of health conditions. The American Epilepsy Society (AES) wants to alert the 3 million people with epilepsy about the myths and facts related to CBD medication – derived from one of the many compounds found in in cannabis (the marijuana plant) – and medical marijuana. Medical marijuana, which is now legal in 29 states as well as the District of Columbia, refers to the physician-prescribed use of the whole, unprocessed marijuana plant or its basic extracts to treat the symptoms of an illness and othe...
Photo: Jaelah Jerger (L) and Vala Jerger (R) (Photo courtesy their mother.) Indiana allows CBD oil for epilepsy, but the girl’s particular form of epilepsy is not protected. It all began last August. Even though the laws in Indiana for cannabis are strict, the Jergers knew there were certain laws permitting CBD oil use for epilepsy patients. Concerned about the side-effects of antiepileptic drug Keppra, they decided to try CBD oil to help with their daughter Jaelah’s seizures, ordering it from a company in Colorado. Then, unexpectedly, Child Protective Services showed up at their door.
Michigan, Texas and many other states are looking at doing what the Texas Department of State Health is thinking about; a crackdown on foods and oils which contain CBD. CBD is a component in marijuana/hemp plants. Unlike THC, the psychedelic active ingredient in cannabis, it cannot actually get you high; it’s frequently utilized to deal with seizure disorders. Texas and other states are proposing a crack down on merchants who sell items consisting of “CBD”, stop selling of illegal and “unapproved” products. Many such over the counter CBD hemp oils have been found to be harmful due to lack of control in manufacturing, dangerous content and filler. CBD and all marijuana products are still illegal under federal law in all states, however CBD crackdowns...
Cannabidiol (CBD) oil has become the hot new product in states that have legalized medical marijuana. The non-intoxicating marijuana extract is being credited with helping treat a host of medical problems — everything from epileptic seizures to anxiety to inflammation to sleeplessness.
Cannabidiol oil comes from the marijuana plant, but it contains only trace amounts, if any, of the compound that produces a high. While cannabidiol oil has no psychoactive effects, it may relieve pain, and it shows some promise as a treatment for migraines. More research is needed to determine whether cannabidiol (CBD) oil is safe and effective. Also, because products derived from the marijuana, or cannabis, plant tend to be unregulated, it is difficult to ensure the quality and quantity of ingredients.
While they are similar in some ways, there are important differences between hemp oil and CBD oil. As a consumer, it’s easy to get confused by phrases such as “cannabis oil” and “marijuana oil,” especially when many companies seem to use these terms interchangeably. Let’s take a closer look at hemp oil and CBD oil to learn how to distinguish the two. Hemp and marijuana are cousins in the plant world. Hemp oil and CBD oil come from different strains of the Cannabis sativa plant. However, hemp oil contains low levels of CBD – typically less than 25 parts per million – while CBD oil can be up to 15% CBD. Because the plants are related, some unscrupulous sellers of hemp oil are trying to market it for its medicinal value, which is negligible.
Marijuana’s effect on the body has garnered more and more interest as it becomes legal for medical and recreational use in different states. People who are against marijuana legalization cite the potential for addiction and other dangerous side effects, but a new report may debunk this popularly-held belief. On Dec. 13, the World Health Organization (WHO) announced that a cannabis compound called cannabidiol (CBD) “could have therapeutic value” for epilepsy-related seizures. Additionally, the WHO says that CBD is not likely to be misused or create dependence, unlike other cannabis compounds like Tetra Hydro Cannabinol (THC).
Since medicinal cannabis has become a more commonplace alternative for a well-established list of ailments, patients are finding a place for it next to their Advil and Tums. But unlike many other chronic illnesses that can be managed with over-the-counter supplements, epilepsy requires a specific cocktail of chemicals not readily available at the local corner store.
People buying a medicinal marijuana extract over the internet often don’t get what they paid for, a new study warns. Nearly 7 out of 10 cannabidiol (CBD) products tested did not contain the amount of marijuana extract promised on the label, researchers report. “We wanted to see if they are accurately describing what is in their product,” said lead researcher Marcel Bonn-Miller. “We found that generally speaking, no, they’re not. There are some people that are doing it right, but the majority of people in the industry are not,” said Bonn-Miller. He is an adjunct assistant professor of psychology in psychiatry at the University of Pennsylvania School of Medicine.
A CBD-based pharmaceutical drug in development is one more step closer to potential FDA approval. Earlier this week, London-based GW Pharmaceuticals plc, which operates in the United States as Greenwich Biosciences, wrapped up its New Drug Application for Epidiolex, a formulation of the cannabis compound cannabidiol (CBD) for the treatment of seizures associated with two specific types of epilepsy: Lennox-Gastaut syndrome and Dravet syndrome.
It’s a buzzy trend in the wellness world, and while CBD is one of the compounds found in the cannabis plant, don’t worry — it won’t get you high. Here’s what you need to know about the latest ingredient everyone’s talking about. What is CBD? CBD is the abbreviation for cannabidiol, one of the many cannabinoids, or chemical compounds, found in marijuana and hemp. You’re probably already familiar with THC, which is another compound found in the cannabis plant. But unlike THC, CBD is not psychoactive. In other words, it’s not what gets you stoned. It’s also different from medical marijuana, which has been shown to reduce pain.